Methotrexate: The best choice for second-line maintenance treatment in active Crohn's disease?

被引：1
|
作者：
Grimaldi, C. [1 ]
机构：
[1] Cabinet Med Hepatogastroenterol, F-06300 Nice, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2009年 / 33卷 / 01期
关键词：
REMISSION;
D O I：
10.1016/j.gcb.2008.09.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [11] Dietary treatment of active Crohn's disease - Dietary treatment is best for children
    WalkerSmith, JA
    BRITISH MEDICAL JOURNAL, 1997, 314 (7097): : 1827 - 1827
  • [12] Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?
    Cannistra, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1158 - 1160
  • [13] What is a best choice at the second-line chemotherapy for advanced or recurrent gastric cancer?
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [14] Methotrexate: first-line or second-line immunomodulator?
    Fraser, AG
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (03) : 225 - 231
  • [15] Combining bevacizumab with chemotherapy—from maintenance to second-line treatment
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (11) : 621 - 621
  • [16] Methotrexate for the treatment of refractory Crohn's disease
    Lemann, M
    ChamiotPrieur, C
    Mesnard, B
    Halphen, M
    Messing, B
    Rambaud, JC
    Gendre, JP
    Colombel, JF
    Modigliani, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) : 309 - 314
  • [17] A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
    Feagan, BG
    Fedorak, RN
    Irvine, EJ
    Wild, G
    Sutherland, L
    Steinhart, AH
    Greenberg, GR
    Koval, J
    Wong, CJ
    Hopkins, M
    Hanauer, SB
    McDonald, JWD
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (22): : 1627 - 1632
  • [18] Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease
    Feagan, BG
    EUROPEAN JOURNAL OF SURGERY, 1998, 164 (12) : 903 - 909
  • [19] A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease.
    Feagan, BG
    Fedorak, RN
    Irvine, EJ
    Wild, GE
    Sutherland, LR
    Steinhart, AH
    Greenberg, G
    Koval, J
    Wong, CJ
    GASTROENTEROLOGY, 2000, 118 (04) : A190 - A190
  • [20] New:: Infliximab (REMICADE®) now approved as second-line treatment in Morbus Crohn
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2006, 44 (11): : C1 - C4
12345